Traumatic Injury: Clinical Trials

7 trials for Traumatic Injury, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 completed, 2 recruiting, 1 terminated, 1 unknown. 7 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 37Completed 3, Recruiting 2, Terminated 1, Unknown 1

Follow Traumatic Injury: new trials by email Literature Review of Traumatic Injury trials Research Report on Traumatic Injury

Trials (filtered) newest first · largest first

All 7 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Prehospital Analgesia INtervention Trial (PAIN)
Ketamine Hydrochloride, Fentanyl Citrate - Traumatic Injury
Phase 3RecruitingJason Sperry9942023-11-272026-03-09
Enantyum® IV Versus Piroxen® IM in Emergency Pain Management
Dexketoprofen, Piroxicam - Traumatic Injury
Phase 3UnknownRiadh Boukef3002023-07-152024-05-08
Evaluation of BE1116 in Patients With Traumatic Injury and Acute Major Bleeding to Improve Survival ( TAP Study )
BE1116, Placebo - Traumatic Injury
Phase 3TerminatedCSL Behring13662023-03-282025-12-10
DSUVIA Early Evaluation of Pain Trial
Sufentanil 30 MCG Sublingual Tablet, standard care pain treatment - Traumatic Injury
Phase 3CompletedFrank Guyette1502022-08-052025-04-30
Ketamine Low dOse Evaluation on Morphine Consumption in Traumatic Patient
Administration of drug - Traumatic Injury
Phase 3CompletedAssistance Publique Hopitaux De Marseille1402022-08-052026-02-04
Type O Whole Blood and Assessment of Age During Prehospital Resuscitation Trial
low titer whole blood, Standard Care - Hemorrhagic Shock, Traumatic Injury
Phase 3CompletedJason Sperry10202022-04-192026-02-12
ErythroPOietin Alfa to Prevent Mortality and Reduce Severe Disability in Critically Ill TRAUMA Patients
Epoetin Alfa 40000 UNT/ML, Sodium Chloride 0.9% - Trauma, Traumatic Injury
Phase 3RecruitingAustralian and New Zealand Intensive Care Research Centre25002020-11-092025-07-16

Narrower conditions

Wounds and Injuries (7)  ·  Agnosia (1)  ·  Brain Injuries, Traumatic (1)  ·  Hemorrhage (1)  ·  Multiple Trauma (1)  ·  Pain (1)  ·  Shock (1)  ·  Shock, Hemorrhagic (1)  ·  Wounds, Nonpenetrating (1)  ·  Wounds, Penetrating (1)

Broader conditions

Pathological Conditions, Signs and Symptoms (3)  ·  Nervous System Diseases (2)  ·  Neurologic Manifestations (2)  ·  Pathologic Processes (2)  ·  Signs and Symptoms (2)  ·  Brain Diseases (1)  ·  Brain Injuries (1)  ·  Central Nervous System Diseases (1)  ·  Craniocerebral Trauma (1)  ·  Neurobehavioral Manifestations (1)  ·  Perceptual Disorders (1)  ·  Shock (1)  ·  Trauma, Nervous System (1)

Interventions

Administration, Inhalation (1)  ·  Administration, Sublingual (1)  ·  Epoetin Alfa (1)  ·  Fentanyl (1)  ·  Ketamine (1)  ·  Piroxicam (1)  ·  Sodium Chloride (1)  ·  Standard of Care (1)  ·  Sufentanil (1)  ·  dexketoprofen trometamol (1)  ·  factor IX, factor VII, factor X, prothrombin drug combination (1)

Sponsors

Jason Sperry (2)  ·  Assistance Publique Hopitaux De Marseille (1)  ·  Australian and New Zealand Intensive Care Research Centre (1)  ·  CSL Behring (1)  ·  Frank Guyette (1)  ·  Riadh Boukef (1)

Countries

United States (4)  ·  Australia (2)  ·  Belgium (1)  ·  Finland (1)  ·  France (1)  ·  Germany (1)  ·  Ireland (1)  ·  New Zealand (1)  ·  Saudi Arabia (1)  ·  Slovenia (1)  ·  Switzerland (1)  ·  Tunisia (1)  ·  United Kingdom (1)

Top investigators

Jason Sperry, MD (2)  ·  Associate Professor Craig French (1)  ·  Jason L Sperry, MD (1)  ·  Professor Alistair Nichol (1)

Results publications

PMID 26452709, PMID 38531812, PMID 39919020, PMID 40271704, PMID 42150044, PMID 42310772